Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $136M invested in Corvus Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
22% more funds holding
Funds holding: 50 → 61 (+11)
4.64% more ownership
Funds ownership: 61.8% → 66.43% (+4.6%)
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
Holders
61
Holding in Top 10
2
Calls
$7.17M
Puts
$2.8M
Top Buyers
| 1 | +$18.1M | |
| 2 | +$16.6M | |
| 3 | +$3.55M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.18M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.78M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$7.25M | |
| 3 | -$5.37M | |
| 4 |
CA
CHI Advisors
New York
|
-$2.68M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.05M |